Cargando…

Chloroquine for COVID-19 Infection

Detalles Bibliográficos
Autor principal:	Moore, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138193/ https://www.ncbi.nlm.nih.gov/pubmed/32266694 http://dx.doi.org/10.1007/s40264-020-00933-4

Ejemplares similares

COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

Chloroquine for COVID-19: rationale, facts, hopes
por: Cortegiani, Andrea, et al.
Publicado: (2020)

Chloroquine and COVID-19, where do we stand?()
por: Lecuit, M.
Publicado: (2020)

Chloroquine and COVID-19: A western medical and scientific drift?
por: Million, Matthieu, et al.
Publicado: (2020)

Chloroquine/hydroxycloroquine and COVID-19: need to know more about
por: Cassone, Antonio, et al.
Publicado: (2020)

The many mechanisms of action of Chloroquine: to use or not to use (in COVID‐19) that is the question
por: Cirino, Giuseppe, et al.
Publicado: (2020)

Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19
por: D’Acquarica, Ilaria, et al.
Publicado: (2020)

Of chloroquine and COVID-19
por: Touret, Franck, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
por: Carafoli, Ernesto
Publicado: (2021)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Combating COVID-19 with Chloroquine
por: Hong, Wanjin
Publicado: (2020)

Treating COVID-19 with Chloroquine
por: Huang, Mingxing, et al.
Publicado: (2020)

The influence of bitter-taste receptor (TAS2R) expression in pharmacological response to Chloroquine in obese patients with COVID-19
por: Watanabe, Lígia Moriguchi, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Population-based meta-analysis of chloroquine: informing chloroquine pharmacokinetics in COVID-19 patients
por: Yao, Xueting, et al.
Publicado: (2020)

QTc interval prolongation, COVID-19 and chloroquine
por: Wiwanitkit, V.
Publicado: (2020)

Hochdosiertes Chloroquin bei COVID-19 gefährlich
Publicado: (2020)

Risks of chloroquine or hydroxychloroquine use for COVID-19
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
por: Ho, Tzu-Chuan, et al.
Publicado: (2021)

Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
por: Singh, Bhagteshwar, et al.
Publicado: (2021)

Evidence for Chloroquine/Hydroxychloroquine in the Treatment of COVID-19
por: Shetty, Rajesh M, et al.
Publicado: (2021)

Efficacy and Safety of Anti-malarial Drugs (Chloroquine and Hydroxy-Chloroquine) in Treatment of COVID-19 Infection: A Systematic Review and Meta-Analysis
por: Das, Rashmi Ranjan, et al.
Publicado: (2020)

Hydroxychloroquine/ chloroquine as a treatment choice or prophylaxis for Covid-19 at the primary care level in developing countries: A Primum non Nocere dilemma
por: Medina, Marco T., et al.
Publicado: (2020)

Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?
por: Kamp, Timothy J., et al.
Publicado: (2020)

Caution and clarity required in the use of chloroquine for COVID-19
por: Wong, Yin Kwan, et al.
Publicado: (2020)

Chloroquine: A Potential Drug in the COVID-19 Scenario
por: Singh, Ranjana, et al.
Publicado: (2020)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
por: Colson, Philippe, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine increase risk of death in COVID-19
Publicado: (2020)

Chloroquine: Can it be a Novel Drug for COVID-19
por: Badyal, Dinesh Kumar, et al.
Publicado: (2020)

Chloroquine-induced QTc prolongation in COVID-19 patients
por: van den Broek, M. P. H., et al.
Publicado: (2020)

Chloroquine as a prophylactic agent against COVID-19?
por: Gendrot, Mathieu, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter
por: Gupta, Anunay, et al.
Publicado: (2020)

QTc Prolongation in COVID-19 Patients Using Chloroquine
por: Becker, Matthijs L., et al.
Publicado: (2021)

Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
por: Bahadoram, Mohammad, et al.
Publicado: (2021)

COVID-19 Epidemic: Chloroquine, a French Obsession?
por: Lapostolle, Fréderic, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qgh9mj0u0mkhfg847ttmkavni8